{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:24:07Z","timestamp":1779315847970,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.transproceed.2022.08.026","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:46:57Z","timestamp":1665103617000},"page":"2125-2132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Preemptive Second Kidney Transplant Outcomes by Induction Type in the United States"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5737-9742","authenticated-orcid":false,"given":"Samy","family":"Riad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurtis J.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasha","family":"El-Rifai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Larrieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logan","family":"Gylten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja","family":"Kandaswamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2022.08.026_bib0001","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.tp.0000234905.56926.7f","article-title":"Induction immunosuppression","volume":"82","author":"Kirk","year":"2006","journal-title":"Transplantation"},{"issue":"Suppl 3","key":"10.1016\/j.transproceed.2022.08.026_bib0002","first-page":"S1","article-title":"Kidney Disease: Improving Global Outcomes Transplant Work G. KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0003","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1600-6143.2007.01972.x","article-title":"Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab","volume":"7","author":"Kirk","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0004","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ki.2009.377","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary","volume":"77","author":"Kasiske","year":"2010","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"10.1016\/j.transproceed.2022.08.026_bib0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.16502","article-title":"OPTN\/SRTR 2019 Annual Data Report: Kidney","volume":"21","author":"Hart","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0006","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/TP.0b013e31827a938f","article-title":"Risks and benefits of preemptive second kidney transplantation","volume":"95","author":"Johnston","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0007","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1681\/ASN.2016010053","article-title":"Premature T cell senescence in pediatric CKD","volume":"28","author":"George","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0008","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/ndt\/gfy276","article-title":"Uraemia-induced immune senescence and clinical outcomes in chronic kidney disease patients","volume":"35","author":"Crepin","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0009","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/tid.12600","article-title":"Immune risk phenotype in kidney transplant recipients: a reliable surrogate for premature immune senescence and increased susceptibility to infection?","volume":"18","author":"Fernandez-Ruiz","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0010","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1009546","article-title":"Alemtuzumab induction in renal transplantation","volume":"364","author":"Hanaway","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0011","doi-asserted-by":"crossref","first-page":"e7151","DOI":"10.1097\/MD.0000000000007151","article-title":"Alemtuzumab versus antithymocyte globulin induction therapies in kidney transplantation patients: A systematic review and meta-analysis of randomized controlled trials","volume":"96","author":"Zheng","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0012","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2008.02519.x","article-title":"Identifying specific causes of kidney allograft loss","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0013","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1432-2277.2012.01448.x","article-title":"Alemtuzumab as compared to alternative contemporary induction regimens","volume":"25","author":"LaMattina","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0014","unstructured":"Riad SM LN, Jackson S, Lake J. Type of induction does not impact patient but not kidney allograft survival in simultaneous liver and kidney transplant recipients in the United States American Transplant Congress 2019; June 2, 2019; Boston, MA."},{"key":"10.1016\/j.transproceed.2022.08.026_bib0015","first-page":"157","article-title":"Induction type does not influence kidney graft or patient survival in recipients with a previous lung transplant in the United States","volume":"39","author":"Riad","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0016","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/TP.0000000000003758","article-title":"Kidney allograft and recipient survival after heart transplantation by induction type in the United States","volume":"106","author":"Riad","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0017","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1681\/ASN.2013060663","article-title":"Polyclonal antithymocyte globulin and cardiovascular disease in kidney transplant recipients","volume":"25","author":"Ducloux","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0018","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/lt.22033","article-title":"Features of immune senescence in liver transplant recipients with established grafts","volume":"16","author":"Gelson","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0019","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.3389\/fimmu.2020.01972","article-title":"Immunosuppression has long-lasting effects on circulating follicular regulatory T cells in kidney transplant recipients","volume":"11","author":"Niu","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0020","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/ndt\/gfn778","article-title":"The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients","volume":"24","author":"Sewgobind","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0021","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/TP.0b013e318247a717","article-title":"Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantation","volume":"93","author":"Macedo","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0022","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/TP.0000000000000507","article-title":"Clinical outcomes associated with induction regimens among retransplant kidney recipients in the United States","volume":"99","author":"Schold","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0023","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0024","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/TP.0000000000000890","article-title":"Risk Factors for BK polyoma virus treatment and association of treatment with kidney transplant failure: insights from a paired kidney analysis","volume":"100","author":"Thangaraju","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0025","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/ndt\/gfw086","article-title":"Efficacy and safety of antibody induction therapy in the current era of kidney transplantation","volume":"31","author":"Opelz","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0026","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.tp.0000179639.98338.39","article-title":"Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression","volume":"80","author":"Caillard","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0027","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.18632\/oncotarget.26859","article-title":"Gender differences in cancer risk after kidney transplantation","volume":"10","author":"Buxeda","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0028","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ckj\/sfx122","article-title":"Risk factors associated with post-kidney transplant malignancies: an article from the Cancer-Kidney International Network","volume":"11","author":"Sprangers","year":"2018","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0029","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/TP.0b013e31817c6447","article-title":"Epidemiology of BK virus in renal allograft recipients: independent risk factors for BK virus replication","volume":"86","author":"Dadhania","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0030","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/ndt\/gfn671","article-title":"Risk factors for polyoma virus nephropathy","volume":"24","author":"Prince","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0031","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40472-015-0052-y","article-title":"The Cost of Transplant immunosuppressant therapy: is this sustainable?","volume":"2","author":"James","year":"2015","journal-title":"Curr Transplant Rep"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0032","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00000658-200108000-00004","article-title":"2,500 living donor kidney transplants: a single-center experience","volume":"234","author":"Matas","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0033","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/TP.0b013e31816349b5","article-title":"HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies","volume":"85","author":"Wissing","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.08.026_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamcollsurg.2016.07.004","article-title":"Insurance type and solid organ transplantation outcomes: a historical perspective on how medicaid expansion might impact transplantation outcomes","volume":"223","author":"DuBay","year":"2016","journal-title":"J Am Coll Surg"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134522005875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134522005875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:42:49Z","timestamp":1758577369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134522005875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0041134522005875"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.08.026","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preemptive Second Kidney Transplant Outcomes by Induction Type in the United States","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.08.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}